Top Guidelines Of phenobarbital sodium tablets

Top Guidelines Of phenobarbital sodium tablets

Blog Article

pentobarbital will lessen the level or effect of eplerenone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unknown.

pentobarbital will decrease the extent or effect of lorlatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital boosts toxicity of methoxyflurane by raising metabolism. Contraindicated. Enhanced metabolism of methoxyflurane to nephrotoxic compounds.

pentobarbital will minimize the level or effect of bazedoxifene/conjugated estrogens by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.

pentobarbital will minimize the level or effect of stiripentol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. If unable to stay clear of coadministration of stiripentol with solid CYP3A4 inducers, boost stiripentol dose.

5. Normal lethal amount, the upper finish on the selection involves those that obtained some supportive cure.

pentobarbital boosts toxicity of ifosfamide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. CYP3A4 inducers may raise the metabolism of ifosfamide to its Energetic alkylating metabolites.

pentobarbital will lessen the level or effect of methylprednisolone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.

pentobarbital will raise the level or effect of clopidogrel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye click here on.

Minor (one)pentobarbital will reduce the extent or effect of paclitaxel protein bound by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Mysterious.

pentobarbital will minimize the extent or effect of doxorubicin liposomal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.

Keep track of Intently (one)pentobarbital will lower the level or effect of osilodrostat by influencing hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will minimize the level or effect of elbasvir/grazoprevir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic effect of elbasvir/grazoprevir might be lowered if coadministered with sturdy CYP3A inducers and is also thus contraindicated.

pentobarbital will lower the level or effect of cilostazol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.